1. Accueil
  2. Publications

Publications

Résultats trouvés 61
Auteur Titre Type [ Année(Desc)]
Filtres: First Letter Of Last Name is L  [Réinitialiser les filtres]
2022
Lafuente-Lafuente C, Rainone A, GuÉrin O, Drunat O, Jeandel C, Hanon O, Belmin J.  2022.  COVID-19 Outbreaks in Nursing Homes Despite Full Vaccination with BNT162b2 of a Majority of Residents.. Gerontology. :1-9.
Couderc A-L, Villani P, Berbis J, Nouguerède E, Rey D, Rossi D, Lechevallier É, Badinand D, Bastide C, Karsenty G et al..  2022.  HoSAGE: sarcopenia in older patient with intermediate / high-risk prostate cancer, prevalence and incidence after androgen deprivation therapy: study protocol for a cohort trial.. BMC Cancer. 22(1):78.
Beaudart C, Bonnefoy M, Gilbert T, Paillaud E, Raynaud-Simon A, GuÉrin O, Jeandel C, Le Sourd B, Haine M, Ferry M et al..  2022.  Quality of life and sarcopenic patients.. Geriatr Psychol Neuropsychiatr Vieil.
Boisteau E, François E, Aparicio T, Le Malicot K, Boulahssass R, Lecomte T, Laurent-Puig P, Guiu B, Paillaud E, Galais M-P et al..  2022.  SOCRATE-PRODIGE 55 trial: A randomized phase II study to evaluate second-line ramucirumab alone or with paclitaxel in older patients with advanced gastric cancer.. Dig Liver Dis. 54(6):747-754.
Boisteau E, François E, Aparicio T, Le Malicot K, Boulahssass R, Lecomte T, Laurent-Puig P, Guiu B, Paillaud E, Galais M-P et al..  2022.  SOCRATE-PRODIGE 55 trial: A randomized phase II study to evaluate second-line ramucirumab alone or with paclitaxel in older patients with advanced gastric cancer.. Dig Liver Dis. 54(6):747-754.
Boisteau E, François E, Aparicio T, Le Malicot K, Boulahssass R, Lecomte T, Laurent-Puig P, Guiu B, Paillaud E, Galais M-P et al..  2022.  SOCRATE-PRODIGE 55 trial: A randomized phase II study to evaluate second-line ramucirumab alone or with paclitaxel in older patients with advanced gastric cancer.. Dig Liver Dis. 54(6):747-754.
Boisteau E, François E, Aparicio T, Le Malicot K, Boulahssass R, Lecomte T, Laurent-Puig P, Guiu B, Paillaud E, Galais M-P et al..  2022.  SOCRATE-PRODIGE 55 trial: A randomized phase II study to evaluate second-line ramucirumab alone or with paclitaxel in older patients with advanced gastric cancer.. Dig Liver Dis. 54(6):747-754.
Boisteau E, François E, Aparicio T, Le Malicot K, Boulahssass R, Lecomte T, Laurent-Puig P, Guiu B, Paillaud E, Galais M-P et al..  2022.  SOCRATE-PRODIGE 55 trial: A randomized phase II study to evaluate second-line ramucirumab alone or with paclitaxel in older patients with advanced gastric cancer.. Dig Liver Dis. 54(6):747-754.
Boisteau E, François E, Aparicio T, Le Malicot K, Boulahssass R, Lecomte T, Laurent-Puig P, Guiu B, Paillaud E, Galais M-P et al..  2022.  SOCRATE-PRODIGE 55 trial: A randomized phase II study to evaluate second-line ramucirumab alone or with paclitaxel in older patients with advanced gastric cancer.. Dig Liver Dis. 54(6):747-754.
Arlotto S, Legueult K, Blin A, Cortaredona S, Giraud-Gatineau A, Bailly L, Jimeno M-T, Delorme L, Brouqui P, Lagier J-C et al..  2022.  Who Were Hospitalized Deceased Patients from COVID-19 During the First Year of Pandemic? Retrospective Analysis of 1104 Deceased Patients in South of France. J Epidemiol Glob Health. 12(2):196-205.
Arlotto S, Legueult K, Blin A, Cortaredona S, Giraud-Gatineau A, Bailly L, Jimeno M-T, Delorme L, Brouqui P, Lagier J-C et al..  2022.  Who Were Hospitalized Deceased Patients from COVID-19 During the First Year of Pandemic? Retrospective Analysis of 1104 Deceased Patients in South of France. J Epidemiol Glob Health. 12(2):196-205.